Deepak Dalvie

6.0k citations

76 papers · 4.0k indexed · h-index 33

Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism 38
- Inflammatory mediators and NSAID effects 6
- Drug-Induced Hepatotoxicity and Protection 5
Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology 5
Computational Theory and Mathematics top 1%
Organic Chemistry top 2%
- Synthesis and Biological Evaluation 5
Molecular Biology top 5%
- Metabolomics and Mass Spectrometry Studies 5
Oncology
- Drug Transport and Resistance Mechanisms 10
Infectious Diseases
- HIV/AIDS drug development and treatment 5

Co-authors: Amit S. Kalgutkar R. Scott Obach John P. O’Donnell S. Cyrus Khojasteh-Bakht Ping Kang Tim Taylor Qiyue Hu Michael Zientek
Cited by: Pharmacology Biochemistry Computational Theory and Mathematics
Journals: Drug Metabolism and Disposition (25 papers)Chemical Research in Toxicology (10 papers)Xenobiotica (6 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Deepak Dalvie

75 papers receiving 3.9k citations

Peers

Countries citing papers authored by Deepak Dalvie

Since Specialization

Citations

This map shows the geographic impact of Deepak Dalvie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepak Dalvie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepak Dalvie more than expected).

Fields of papers citing papers by Deepak Dalvie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepak Dalvie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepak Dalvie. The network helps show where Deepak Dalvie may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Deepak Dalvie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deepak Dalvie Line = papers co-authored together Deepak Dalvie links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants British Journal of Clinical Pharmacology ·Tian-Ren Sun,Ajay Madan,Kazuyuki Suzuki,Deepak Dalvie,Lance Goulet,R. Scott Struthers,Alan Krasner	2025	0
2	Future of Biotransformation Science in the Pharmaceutical Industry Drug Metabolism and Disposition ·Valerie M. Kramlinger,Deepak Dalvie,C. Battella,Amit S. Kalgutkar,T. M. M.,Dian Su,Aaron M. Teitelbaum,Rheem A. Totah	2021	12
3	Aldehyde oxidase and its role as a drug metabolizing enzyme Pharmacology & Therapeutics ·Deepak Dalvie,Li Di	2019	57
4	Species Differences in the Oxidative Desulfurization of a Thiouracil-Based Irreversible Myeloperoxidase Inactivator by Flavin-Containing Monooxygenase Enzymes Drug Metabolism and Disposition ·Heather Eng,Raman Sharma,Angela Wolford,Li Di,Roger B. Ruggeri,Leonard Buckbinder,Edward L. Conn,Deepak Dalvie,Amit S. Kalgutkar	2016	8
5	Contribution of Membrane Trafficking Perturbation to Retinal Toxicity Toxicological Sciences ·Per Erik Ekholm,Sharon Sokolowski,Bart Jessen,Mark G. Evans,Deepak Dalvie,Shuyan Lu	2015	11
6	Metabolites in Safety Testing Assessment in Early Clinical Development: A Case Study with a Glucokinase Activator Drug Metabolism and Disposition ·Raman Sharma,John Litchfield,Karen Atkinson,Heather Eng,Neeta B. Amin,William S. Denney,John C. Pettersen,Theunis C. Goosen,Li Di,Esther Lee,Jeffrey A. Pfefferkorn,Deepak Dalvie,Amit S. Kalgutkar	2014	15
7	Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance Proceedings of the National Academy of Sciences ·Phillip A. Schwartz,Petr Kuzmič,James Solowiej,Simon Bergqvist,Ben Bolaños,Chau Almaden,Asako Nagata,Kevin Ryan,Junli Feng,Deepak Dalvie,John C. Kath,Meirong Xu,Revati Wani,Brion W. Murray	2013	197
8	Which Metabolites Circulate? Drug Metabolism and Disposition ·Cho‐Ming Loi,Dennis A. Smith,Deepak Dalvie	2013	29
9	Why do metabolites circulate? Xenobiotica ·Dennis A. Smith,Deepak Dalvie	2011	30
10	Comparison of In Vitro Metabolism of Ticlopidine by Human Cytochrome P450 2B6 and Rabbit Cytochrome P450 2B4 Drug Metabolism and Disposition ·Jean-Luc Benoit,Manish B. Shah,Gregory S. Walker,Cathie Xiang,James R. Halpert,Deepak Dalvie	2010	21
11	Metabolism, Pharmacokinetics, and Excretion of a Cholesteryl Ester Transfer Protein Inhibitor, Torcetrapib, in Rats, Monkeys, and Mice: Characterization of Unusual and Novel Metabolites by High-Resolution Liquid Chromatography-Tandem Mass Spectrometry and 1H Nuclear Magnetic Resonance Drug Metabolism and Disposition ·Chandra Prakash,Weichao Chen,Michelle I. Rossulek,Kim A. Johnson,Chenghong Zhang,Thomas N. O’Connell,Michael J. Potchoiba,Deepak Dalvie	2008	21
12	Metabolism Distribution and Excretion of a Matrix Metalloproteinase-13 Inhibitor, 4-[4-(4-Fluorophenoxy)-benzenesulfonylamino]tetrahydropyran-4-carboxylic Acid Hydroxyamide (CP-544439), in Rats and Dogs: Assessment of the Metabolic Profile of CP-544439 in Plasma and Urine of Humans Drug Metabolism and Disposition ·Deepak Dalvie,S. Wang,Tracey Boyden,Sue Zhou,Camila Pauleski Zucuni,Michael J. Potchoiba	2008	29
13	Bioactivation of Flutamide Metabolites by Human Liver Microsomes Drug Metabolism and Disposition ·Ping Kang,Deepak Dalvie,Evan Smith,Sue Zhou,Alan Deese,James A. Nieman	2008	41
14	Identification of primary and sequential bioactivation pathways of carbamazepine in human liver microsomes using liquid chromatography/tandem mass spectrometry Rapid Communications in Mass Spectrometry ·Hai‐Zhi Bu,Ping Zhao,Deepak Dalvie,William F. Pool	2007	17
15	Genotoxicity of 2-(3-Chlorobenzyloxy)-6-(piperazinyl)pyrazine, a Novel 5-Hydroxytryptamine2c Receptor Agonist for the Treatment of Obesity: Role of Metabolic Activation Drug Metabolism and Disposition ·Amit S. Kalgutkar,Deepak Dalvie,Jiri Aubrecht,Evan B. Smith,Stephanie L. Coffing,Zhengang Sun,曹洪启,Mary E. Lame,Yu-Chu Tseng,Kim F. McClure,Tristan S. Maurer,陳餘鋆,Abhba,Klaas Schildknegt	2007	36
16	MECHANISM-BASED INACTIVATION OF HUMAN RECOMBINANT P450 2C9 BY THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG SUPROFEN Drug Metabolism and Disposition ·John P. O’Donnell,Deepak Dalvie,Amit S. Kalgutkar,R. Scott Obach	2003	56
17	Metabolism of CP-195,543, a leukotriene B4 receptor antagonist, in the Long-Evans rat and Cynomolgus monkey Xenobiotica ·Deepak Dalvie,John P. O’Donnell	1999	9
18	Metabolism of pamaqueside, a cholesterol absorption inhibitor, in Long-Evans rat: effect of bile duct cannulation on absorption Xenobiotica ·Deepak Dalvie,John P. O’Donnell	1999	3
19	Carbamates of (hydroxyphenoxy)methyl heteroaromatic salts as acetylcholinesterase inhibitors and protective agents against organophosphorus compounds Chemical Research in Toxicology ·Richard J. Sundberg,Deepak Dalvie,Norma Reyes,Michal Sabat,H. A. MUSALLAM	1993	7
20	Design, synthesis, and biological evaluation of novel 4-substituted 1-methyl-1,2,3,6-tetrahydropyridine analogs of MPTP Journal of Medicinal Chemistry ·Zhiyang Zhao,Deepak Dalvie,Noreen Naiman,Kay Castagnoli,Neal Castagnoli	1992	24

About Deepak Dalvie

Deepak Dalvie is a scholar working on Pharmacology, Biochemistry, Toxicology, Oncology and Pharmacology, having authored 76 papers that have together received 4.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (38 papers), Drug Transport and Resistance Mechanisms (10 papers), Inflammatory mediators and NSAID effects (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers), Eicosanoids and Hypertension Pharmacology (5 papers), HIV/AIDS drug development and treatment (5 papers), Synthesis and Biological Evaluation (5 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). The work is most often cited by research in Pharmacology (1.5k citations), Biochemistry (312 citations), Computational Theory and Mathematics (607 citations), Organic Chemistry (831 citations) and Molecular Biology (1.7k citations). Deepak Dalvie has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Amit S. Kalgutkar, R. Scott Obach, John P. O’Donnell, S. Cyrus Khojasteh-Bakht, Ping Kang, Tim Taylor, Qiyue Hu, John P. O’Donnell, Michael Zientek and R. Foti. Their work appears in journals such as Drug Metabolism and Disposition, Chemical Research in Toxicology, Xenobiotica, Journal of Medicinal Chemistry and Drug Metabolism Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact